Literature DB >> 12094614

Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production.

F Y Tang1, M Meydani.   

Abstract

Epidemiological and animal studies have indicated that consumption of green tea and high vitamin E intake are associated with a reduced risk of developing certain forms of cancer. However, the inhibitory mechanism of green tea catechins and vitamin E in angiogenesis, an important process in tumor growth, has not been well established. In the present study, alpha-tocopherol and several major catechins of green tea (catechin, epicatechin, epicatechin gallate, epigallocatechin, and epigallocatechin gallate) were tested for their ability to inhibit tube formation in vitro using a model in which human microvascular endothelial cells were exposed to a constant rate of a physiologically low level of H2O2. In this model, the production of interleukin (IL)-8 by human microvascular endothelial cells at a low level of H2O2 was required for angiogenesis, as assessed by tube formation in three-dimensional gel in culture. Vitamin E (d-alpha-tocopherol, 40 microM) in the culture media significantly reduced IL-8 production and angiogenesis. Among the green tea catechins, epigallocatechin (0.5-1 microM) was the most effective in reducing IL-8 production and inhibiting angiogenesis. These results suggest that consumption of green tea catechins or supplemental intake of vitamin E may have preventive effects on tumor development, mediated, at least in part, through inhibition of angiogenesis via suppression of IL-8 production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12094614     DOI: 10.1080/01635581.2001.9680622

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  14 in total

1.  Steep your genes in health: drink tea.

Authors:  Carolyn M Matthews
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-04

2.  Inhibitory effects of corni fructus extract on angiogenesis and adipogenesis.

Authors:  Jae-Ho Hwang; Jong-Deog Kim
Journal:  Korean J Physiol Pharmacol       Date:  2011-02-28       Impact factor: 2.016

3.  Green tea catechins inhibit angiogenesis through suppression of STAT3 activation.

Authors:  Hoyee Leong; Priya S Mathur; Geoffrey L Greene
Journal:  Breast Cancer Res Treat       Date:  2008-09-28       Impact factor: 4.872

Review 4.  Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy.

Authors:  Masuko Ushio-Fukai; Yoshimasa Nakamura
Journal:  Cancer Lett       Date:  2008-04-10       Impact factor: 8.679

5.  The modulation of endothelial cell gene expression by green tea polyphenol-EGCG.

Authors:  Liping Liu; Chao-Qiang Lai; Lin Nie; Jose Ordovas; Michael Band; Leta Moser; Mohsen Meydani
Journal:  Mol Nutr Food Res       Date:  2008-10       Impact factor: 5.914

6.  Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice.

Authors:  Pornprom Yoysungnoen; Ponthip Wirachwong; Chatchawan Changtam; Apichart Suksamrarn; Suthiluk Patumraj
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

Review 7.  Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function.

Authors:  Masuko Ushio-Fukai; Norifumi Urao
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

Review 8.  Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase.

Authors:  Masuko Ushio-Fukai; R Wayne Alexander
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

9.  Enzyme-digested Fucoidan Extracts Derived from Seaweed Mozuku of Cladosiphon novae-caledoniae kylin Inhibit Invasion and Angiogenesis of Tumor Cells.

Authors:  Jun Ye; Yuping Li; Kiichiro Teruya; Yoshinori Katakura; Akira Ichikawa; Hiroshi Eto; Mutsutaka Hosoi; Masako Hosoi; Shinji Nishimoto; Sanetaka Shirahata
Journal:  Cytotechnology       Date:  2005-01       Impact factor: 2.058

10.  Vitexicarpin acts as a novel angiogenesis inhibitor and its target network.

Authors:  Bo Zhang; Lu Liu; Shiwen Zhao; Xu Wang; Liyang Liu; Shao Li
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.